Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives

Shang-Chin Huang, Chun-Jen Liu

Clin Mol Hepatol. 2023;29(2):320-331. Published online February 1, 2023

DOI: https://doi.org/10.3350/cmh.2022.0422

View: 9116 Download: 482 Web of Science: 45 Crossref: 51

Original Article

Direct comparison of biopsy techniques for hepatic malignancies

Shang-Chin Huang, Ja-Der Liang, Shih-Jer Hsu, Tzu-Chan Hong, Hung-Chih Yang, Jia-Horng Kao

Clin Mol Hepatol. 2021;27(2):305-312. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0301

View: 6401 Download: 173 Web of Science: 11 Crossref: 12

High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction associated steatotic liver disease

Tung-Hung Su, Sheng-Shun Yang, Mei-Hsuan Lee, Wei-Yu Kao, Shang-Chin Huang, Fen-Fang Chen, Francis SK Poon, Lung-Wen Tsai, Yi-Ting Chen, Che Lin, Weichung Wang, W Ray Kim, Jia-Horng Kao

Received September 21, 2024 Accepted January 1, 2025

DOI: https://doi.org/10.3350/cmh.2024.0822 [Accepted]

View: 1403 Download: 152

Editorial

Metabolic Health in Antiviral Era of Chronic Hepatitis B

Shang-Chin Huang, Jia-Horng Kao

Received April 3, 2025 Accepted April 8, 2025

DOI: https://doi.org/10.3350/cmh.2025.0369 [Accepted]

View: 305 Download: 21

Reply to Correspondence

Advancing Metabolic Risk Profiling in Chronic Hepatitis B

Shang-Chin Huang, Jia-Horng Kao

Received May 4, 2025 Accepted May 8, 2025

DOI: https://doi.org/10.3350/cmh.2025.0500 [Accepted]

View: 187 Download: 10

1 |

Viewed By 11936	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7474	MAFLD: How is it different from NAFLD?
Viewed By 6566	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5732	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 5349	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 355	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 331	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 223	MAFLD: How is it different from NAFLD?
Cited By 114	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 110	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search